Evidence map›Paper›PMID 33763084›Full record

ArticleFrontiers in immunology2021

ADP-Ribosylation Regulates the Signaling Function of IFN-γ.

Stephan Menzel, Tomas Koudelka, Björn Rissiek, Friedrich Haag, Catherine Meyer-Schwesinger, Andreas Tholey, Friedrich Koch-Nolte

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. An unconventional purine connection.The Journal of experimental medicine · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Functional roles of ADP-ribosylation writers, readers and erasers.Frontiers in cell and developmental biology · 2022
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Stephan MenzelInstitute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Tomas KoudelkaInstitute of Experimental Medicine, AG Systematic Proteome Research and Bioanalytics, Christian-Albrechts-Universität, Kiel, Germany.
Björn RissiekDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Friedrich HaagInstitute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Catherine Meyer-SchwesingerInstitute of Cellular and Integrative Physiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Andreas TholeyInstitute of Experimental Medicine, AG Systematic Proteome Research and Bioanalytics, Christian-Albrechts-Universität, Kiel, Germany.
Friedrich Koch-NolteInstitute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
University Medical Center Hamburg-Eppendorf · DEKiel University · DEUniversität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Murine T cells express the GPI-anchored ADP-ribosyltransferase 2.2 (ARTC2.2) on the cell surface. In response to T cell activation or extracellular NAD

Indexed as

ADP Ribose TransferasesADP-RibosylationAnimalsInterferon-gammaMiceMice, Inbred C57BLSignal TransductionADP Ribose TransferasesARTC2.2 protein, mouseInterferon-gammaADP-ribosylationinterferon-gammaNAD+purinergic signalingT cells

Identifiers

PMID33763084
PMCPMC7983947
OpenAlexW3135433095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.